Skip to main content
Annals of Intensive Care
Fig. 4 | Annals of Intensive Care

Fig. 4

From: Infectious events in patients with severe COVID-19: results of a cohort of patients with high prevalence of underlying immune defect

Fig. 4

Competing risk of cumulative incidence of hospital-acquired infections in patients admitted to the ICU for severe COVID-19 according to dexamethasone intake. a Competing risk of hospital-acquired infections (red), ICU mortality (green) and ICU discharge (blue) in patients according to dexamethasone intake before matching. b Competing risk of hospital-acquired infections (red), ICU mortality (green) and ICU discharge (blue) in patients according to dexamethasone intake after matching on dexamethasone using a propensity score analysis

Back to article page